T-cell study adds to debate over duration of Covid-19 immunity
A small UK study has
found that "cellular immunity" to the pandemic SARS-CoV-2 virus is
present after six months in people who had mild or asymptomatic Covid-19
infections - suggesting they might have some level of protection for at
least that time.
Scientists presenting
the findings, from 100 non-hospitalised Covid-19 patients in Britain,
said they were "reassuring" but did not mean people cannot in rare cases
be infected twice with the disease.
"There is still a lot for us learn before we have a full understanding of how immunity to Covid-19 works."
The study, which has
not yet been peer-reviewed by other experts but was published online on
bioRvix, analysed the blood of 100 patients six months after they had
had either mild or asymptomatic Covid-19. It found that while some of
the patients' antibody levels had
dropped, their T-cell response - another key part of the immune system -
remained robust.
"(Our) early results show that T-cell responses may outlast the initial
antibody response," said Shamez Ladhani, a consultant epidemiologist at Public Health
England who co-led the work.
The researchers said
this could be interpreted in two ways: It is possible that higher
cellular immunity might give better protection against re-infection in
people who had symptoms, or equally, that asymptomatic patients are
better able to fight off the virus without the
need to generate a large immune response.
"These results provide
reassurance that, although the titre of antibody to SARS-CoV-2 can fall
below detectable levels within a few months of infection, a degree of
immunity to the virus may be maintained," said Charles Bangham, chair of
immunology at Imperial College London.
While more than 46 million people worldwide have been infected with Covid-19, confirmed cases of re-infection are so far very rare.